JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 88.21 Million CNY | 50.14% |
| 2022 | 58.75 Million CNY | 549.6% |
| 2021 | 9.04 Million CNY | 0.0% |
| 2020 | - CNY | -100.0% |
| 2019 | 5.48 Million CNY | 2450.23% |
| 2018 | 215 Thousand CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3 Million USD | 0.0% |
| 2024 Q1 | 3.02 Million USD | 295.11% |
| 2023 Q4 | 766.68 Thousand USD | -74.21% |
| 2023 FY | 88.21 Million CNY | 50.14% |
| 2023 Q3 | 2.97 Million USD | 163.44% |
| 2023 Q2 | 1.12 Million USD | -65.42% |
| 2023 Q1 | 3.26 Million USD | 776.67% |
| 2022 Q4 | 372.16 Thousand USD | -85.14% |
| 2022 FY | 58.75 Million CNY | 549.6% |
| 2022 Q2 | -940.57 Thousand USD | 0.0% |
| 2022 Q3 | 2.5 Million USD | 366.18% |
| 2021 Q4 | -2.36 Million USD | 0.0% |
| 2021 Q2 | -2.43 Million USD | 0.0% |
| 2021 FY | 9.04 Million CNY | 0.0% |
| 2020 Q4 | -1.9 Million USD | 0.0% |
| 2020 FY | - CNY | -100.0% |
| 2020 Q2 | -1.51 Million USD | 0.0% |
| 2019 FY | 5.48 Million CNY | 2450.23% |
| 2019 Q4 | -1.48 Million USD | 0.0% |
| 2019 Q2 | -1.02 Million USD | 0.0% |
| 2018 FY | 215 Thousand CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -488.166% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -2843839.394% |
| SQZ Biotechnologies Company | 9.79 Million USD | -800.745% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -653.622% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 25.933% |
| Mesoblast Limited | -35.16 Million USD | 350.85% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 258427.965% |
| Genus plc | 178.7 Million USD | 50.633% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -21408.174% |
| Marizyme, Inc. | 457.7 Thousand USD | -19174.331% |
| ContraFect Corporation | -154 Thousand USD | 57385.065% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 802090.909% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 176538.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -114826.851% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -134118.294% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 22866.135% |
| MultiCell Technologies, Inc. | 49.32 USD | -178870540.714% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -119.096% |
| EV Biologics, Inc. | 48.9 Thousand USD | -180306.953% |
| Q BioMed Inc. | -8988.00 USD | 981619.804% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -212.224% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 572059.284% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 59.919% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -125927.143% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 71100.636% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -141671.928% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 1781582.229% |
| Arch Therapeutics, Inc. | -2439.00 USD | 3617115.17% |
| IMV Inc. | -962.29 Thousand USD | 9267.534% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -62689.324% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 90567.108% |
| GB Sciences, Inc. | -624.00 USD | 14137760.256% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 102646.845% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 98.833% |
| Halberd Corporation | -208.00 USD | 42413080.769% |
| Enzolytics Inc. | 30.7 Thousand USD | -287183.444% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -6400.347% |
| SYBLEU INC | 11.69 Thousand USD | -754166.416% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -18186.27% |
| argenx SE | 1.1 Billion USD | 92.041% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 441.961% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -14189.162% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 78.46% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 996249.503% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -98.88% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 7827.852% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -8829.22% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -817.896% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 105311.75% |
| BioStem Technologies, Inc. | 15.42 Million USD | -471.928% |
| ONE Bio Corp. | 20.12 Million USD | -338.346% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 745507.689% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 182903.208% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -49865.451% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -49865.451% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 17246.217% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 14099.949% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 304303.448% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -19502.349% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 27710.976% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -1814.475% |
| Bioxytran, Inc. | -8285.00 USD | 1064903.862% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 23751.206% |
| Neutra Corp. | 14.33 Thousand USD | -615309.836% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 107684.146% |
| PureTech Health plc | -1.6 Million USD | 5603.369% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 8911.01% |
| IXICO plc | 3.27 Million USD | -2597.829% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 12811.671% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 5025.684% |
| CSL Limited | 7.7 Billion USD | 98.855% |
| Cellectis S.A. | 18 Thousand USD | -490005.556% |